Digital therapeutics firm Click Therapeutics will acquire the assets of Better Therapeutics, including a mobile app for Type 2 diabetes patients called AspyreRx, following approval by the FDA. The acquisition comes after Better announced the layoff of all its employees due to lack of capital reserves. Click aims to develop a digital therapeutic for obesity using the acquired assets in combination with metabolic disorder medications.
CISOs take the back seat as dev teams claim responsibility for application security
Development and engineering teams are taking the lead in shaping security measures and budget strategies, ensuring that projects align with both security protocols and financial
